Q-omics provides the consensus-scored CFAP97D2 profile across patient tissues and cancer cell-line models. Additionally, CFAP97D2 RNA expression shows 9,350 significant protein co-abundance associations, with the highest sampling consensus in PDAC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for CFAP97D2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with CFAP97D2 in patient tissues and cancer cell lines. In patient samples, CFAP97D2 shows the broadest associations at the RNA and protein expression levels, with PDAC recurring as the lineage with the largest associated feature set. In cancer cell lines, CFAP97D2 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Leukemia, while CRISPR and shRNA rows add functional-dependency signals in OVARY.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	9,350	PDAC (5777)	view →
Function (mass-spec)	580	PDAC (274)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	879	BLOOD_Leukemia (184)	view →
CRISPR	224	OVARY (74)	view →